First manic episode associated with use of human chorionic gonadotropin for obesity: a case report

Bipolar Disorders
Marsal SanchesJair C Soares

Abstract

Although highly controversial, the treatment of obesity with exogenous human chorionic gonadotropin (HCG) remains popular in the USA. We report the case of a patient whose first manic episode was associated with the use of HCG for weight loss. A 32-year-old female patient was admitted to our psychiatric inpatient unit due to a two-week history of manic symptoms. She had no previous history of manic or hypomanic episodes and had completed a 45-day course of sublingual HCG for weight loss immediately prior to the onset of the manic episode. The patient was treated with lithium carbonate and aripiprazole, and progressed with improvement in the symptoms. While it is not possible to definitively link the HCG use to the development of mania, available evidence suggests that HCG may have a contributing role in triggering manic symptomatology.

References

Nov 4, 1974·JAMA : the Journal of the American Medical Association·J C Ballin, P L White
Mar 21, 1998·The American Journal of Psychiatry·R N Persaud, R W Lam
Feb 13, 2001·Psychoneuroendocrinology·W H MellerG E Tagatz
Sep 27, 2007·Human Reproduction Update·Katherine E WilliamsNatalie L Rasgon

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Related Papers

International Journal of Obesity : Journal of the International Association for the Study of Obesity
J C Lovejoy, M Sasagawa
International Journal of Qualitative Studies on Health and Well-being
Olga G Isupova
© 2021 Meta ULC. All rights reserved